Dr. Geetika Sabharwal, MD

Dr. Sabharwal practices at Allergy Affiliates, Inc. in Bradenton, Florida.

Dr. Sabharwal's NPI, 1457581290, was assigned on July 14, 2009. Dr. Sabharwal graduated from Kasturba Medical College Manipal in 2007. Dr. Sabharwal holds Florida license ME137396.

Dr. Sabharwal's primary practice is Allergy Affiliates, Inc., at 5701 21st W Ave, Bradenton, FL 34209 in Manatee County. The practice phone is (941) 792-4151.

Dr. Sabharwal's primary practice is Allergy Affiliates, Inc. in Bradenton, Florida. The medical group on file is Allergy Affiliates. Dmand AI also links Dr. Sabharwal to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sabharwal practices. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Sabharwal's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Sabharwal is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Sabharwal's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, hives and immune deficiency disease among the conditions Dr. Sabharwal treats.

CMS data shows 13,098 Medicare services from Dr. Sabharwal across 16 procedure codes in 2024, for 307 Medicare patients. Medicare paid $144,387 for them. Every service was in an office.

CMS counts 307 Medicare patients who saw Dr. Sabharwal in 2024. The largest group is 65 to 74, with 166 patients. 75% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sabharwal's median patient age at 48, with 63% women.

In 2024, Dr. Sabharwal wrote 729 Medicare Part D claims for 216 patients. 68% of them were for generic drugs. CMS names the drug for 640 of them, across 16 drugs with 11 or more claims each, at $244,133 in total drug cost. In 2023, CMS named 629 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sabharwal for performance year 2024, reported individually. Dr. Sabharwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sabharwal as offering telehealth.

Dmand AI links 6 papers to Dr. Sabharwal, published from 2015 to 2018. 2018 was the busiest year, with 2. Dr. Sabharwal has published most often in Allergy Asthma Proc. Dr. Sabharwal's most frequent co-authors are Timothy J. Craig, DO, Aparna Susan Daley, MBCHB and Samantha K. Lin, MD.

CMS Open Payments shows 205 general payments to Dr. Sabharwal from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,131.

Dr. Sabharwal graduated from Kasturba Medical College Manipal in 2007.

Dr. Sabharwal is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.